Tumor Volume on PSMA PET As a Prognostic Biomarker in Prostate Cancer Patients Treated with Cabazitaxel.

Qaid Ahmed Shagera,Ioannis Karfis,Spyridon Sideris,Thomas Guiot,Erwin Woff,Nieves Martinez-Chanza,Thierry Roumeguere,Thierry Gil,Patrick Flamen,Carlos Artigas

Clinical Nuclear Medicine（2023）

Cited 1|Views24
No score
Key words
biomarker,cabazitaxel,PET,CT,prognostic,prostate cancer,PSMA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined